Diabetes Metab J.  2020 Jun;44(3):436-445. 10.4093/dmj.2019.0081.

Association between Higher Blood Pressure and Risk of Diabetes Mellitus in Middle-Aged and Elderly Chinese Adults

• Yang X
• Chen J
• Pan A
• Wu JH
• Zhao F
• Xie Y
• Wang Y
• Ye Y
• Pan XF
• Yang CX

• KMID: 2513001
• DOI: http://doi.org/10.4093/dmj.2019.0081

Abstract

To examine the prospective association between higher blood pressure (BP) and risk of type 2 diabetes mellitus (T2DM) in middle-aged and elderly Chinese adults.

A total of 9,642 middle-aged and elderly Chinese adults (≥45 years old; 47.30% men) without diabetes from the China Health and Retirement Longitudinal Study were included for analyses. Participants were categorized into three groups: normal BP, prehypertension, and hypertension, according to the 2010 Chinese Guidelines for the Management of Hypertension. The incidence of T2DM was determined by self-reported physician diagnosis during two follow-up surveys conducted in 2013 to 2014 and 2015 to 2016.

During the 4-year follow-up, 429 participants (4.45%) developed T2DM, including 3.51% of the men and 5.29% of the women. The incidence rates of T2DM were 2.57%, 3.75%, and 6.71% in the normal BP, prehypertension, and hypertension groups, respectively. After adjustment for age, sex, education level, residence, smoking status, alcohol consumption, body mass index, waist circumference, and dyslipidemia, both prehypertension (odds ratio [OR], 1.32; 95% confidence interval [CI], 0.98 to 1.77) and hypertension (OR, 2.02; 95% CI, 1.54 to 2.64) were associated with increased risk of T2DM, compared to those with a normal BP. The ORs associated with T2DM were 1.08 (95% CI, 1.03 to 1.13) for an increase of 10 mm Hg in systolic BP and 1.06 (95% CI, 1.01 to 1.10) for an increase of 5 mm Hg in diastolic BP.

Higher BP is a risk factor for T2DM in middle-aged and elderly Chines. It may be a potential target for diabetes prevention.

Keyword

Blood pressure; China; Diabetes mellitus; Hypertension

Reference

1. Arauz A, Rodriguez-Agudelo Y, Sosa AL, Chavez M, Paz F, Gonzalez M, Coral J, Diaz-Olavarrieta C, Roman GC. Vascular cognitive disorders and depression after first-ever stroke: the Fogarty-Mexico Stroke Cohort. Cerebrovasc Dis. 2014; 38:284–289. PMID: 25412708.

2. Liu M, Liu SW, Wang LJ, Bai YM, Zeng XY, Guo HB, Liu YN, Jiang YY, Dong WL, He GX, Zhou MG, Yu SC. Burden of diabetes, hyperglycaemia in China from to 2016: findings from the 1990 to 2016, global burden of disease study. Diabetes Metab. 2019; 45:286–293. PMID: 30196138.

3. Wang L, Gao P, Zhang M, Huang Z, Zhang D, Deng Q, Li Y, Zhao Z, Qin X, Jin D, Zhou M, Tang X, Hu Y, Wang L. Prevalence and ethnic pattern of diabetes and prediabetes in China in 2013. JAMA. 2017; 317:2515–2523. PMID: 28655017.

4. Emdin CA, Anderson SG, Woodward M, Rahimi K. Usual blood pressure and risk of new-onset diabetes: evidence from 4.1 million adults and a meta-analysis of prospective studies. J Am Coll Cardiol. 2015; 66:1552–1562. PMID: 26429079.

5. Lacey B, Lewington S, Clarke R, Kong XL, Chen Y, Guo Y, Yang L, Bennett D, Bragg F, Bian Z, Wang S, Zhang H, Chen J, Walters RG, Collins R, Peto R, Li L, Chen Z. China Kadoorie Biobank collaborative group. Age-specific association between blood pressure and vascular and non-vascular chronic diseases in 0.5 million adults in China: a prospective cohort study. Lancet Glob Health. 2018; 6:e641–e649. PMID: 29773120.

6. Wu YT, Song L, Liu XX, Gao JS, Zheng XM, Ruan CY, Zhao HY, Chen SH, Gao WY, Jonas JB, Wu SL. Time-cumulated blood pressure exposure and incident impairment of glucose tolerance and diabetes mellitus. BMC Cardiovasc Disord. 2017; 17:106. PMID: 28464794.

7. Zhao Y, Hu Y, Smith JP, Strauss J, Yang G. Cohort profile: the China Health and Retirement Longitudinal Study (CHARLS). Int J Epidemiol. 2014; 43:61–68. PMID: 23243115.

8. Zhao Y, Crimmins EM, Hu P, Shen Y, Smith JP, Strauss J, Wang Y, Zhang Y. Prevalence, diagnosis, and management of diabetes mellitus among older Chinese: results from the China Health and Retirement Longitudinal Study. Int J Public Health. 2016; 61:347–356. PMID: 26755457.

9. Kim MJ, Lim NK, Choi SJ, Park HY. Hypertension is an independent risk factor for type 2 diabetes: the Korean genome and epidemiology study. Hypertens Res. 2015; 38:783–789. PMID: 26178151.

10. Liu LS. Writing Group of 2010 Chinese Guidelines for the Management of Hypertension. 2010 Chinese guidelines for the management of hypertension. Zhonghua Xin Xue Guan Bing Za Zhi. 2011; 39:579–615. PMID: 22088239.

11. Allison MA, Budoff MJ, Wong ND, Blumenthal RS, Schreiner PJ, Criqui MH. Prevalence of and risk factors for subclinical cardiovascular disease in selected US Hispanic ethnic groups: the Multi-Ethnic Study of Atherosclerosis. Am J Epidemiol. 2008; 167:962–969. PMID: 18283034.

12. Cho NH, Kim KM, Choi SH, Park KS, Jang HC, Kim SS, Sattar N, Lim S. High blood pressure and its association with incident diabetes over 10 years in the Korean Genome and Epidemiology Study (KoGES). Diabetes Care. 2015; 38:1333–1338. PMID: 25986660.

13. Hayashi T, Tsumura K, Suematsu C, Endo G, Fujii S, Okada K. High normal blood pressure, hypertension, and the risk of type 2 diabetes in Japanese men. The Osaka Health Survey. Diabetes Care. 1999; 22:1683–1687. PMID: 10526735.

14. Aikens RC, Zhao W, Saleheen D, Reilly MP, Epstein SE, Tikkanen E, Salomaa V, Voight BF. Systolic blood pressure and risk of type 2 diabetes: a Mendelian randomization study. Diabetes. 2017; 66:543–550. PMID: 27702834.

15. Cheung BM, Li C. Diabetes and hypertension: is there a common metabolic pathway? Curr Atheroscler Rep. 2012; 14:160–166. PMID: 22281657.

16. Sesso HD, Buring JE, Rifai N, Blake GJ, Gaziano JM, Ridker PM. C-reactive protein and the risk of developing hypertension. JAMA. 2003; 290:2945–2951. PMID: 14665655.

17. Bautista LE, Vera LM, Arenas IA, Gamarra G. Independent association between inflammatory markers (C-reactive protein, interleukin-6, and TNF-alpha) and essential hypertension. J Hum Hypertens. 2005; 19:149–154. PMID: 15361891.

18. Odegaard AO, Jacobs DR Jr, Sanchez OA, Goff DC Jr, Reiner AP, Gross MD. Oxidative stress, inflammation, endothelial dysfunction and incidence of type 2 diabetes. Cardiovasc Diabetol. 2016; 15:51. PMID: 27013319.

19. Meigs JB, Hu FB, Rifai N, Manson JE. Biomarkers of endothelial dysfunction and risk of type 2 diabetes mellitus. JAMA. 2004; 291:1978–1986. PMID: 15113816.

20. Meigs JB, O'donnell CJ, Tofler GH, Benjamin EJ, Fox CS, Lipinska I, Nathan DM, Sullivan LM, D'Agostino RB, Wilson PW. Hemostatic markers of endothelial dysfunction and risk of incident type 2 diabetes: the Framingham Offspring Study. Diabetes. 2006; 55:530–537. PMID: 16443791.

21. Wang F, Han L, Hu D. Fasting insulin, insulin resistance and risk of hypertension in the general population: a meta-analysis. Clin Chim Acta. 2017; 464:57–63. PMID: 27836689.

22. Elliott WJ, Meyer PM. Incident diabetes in clinical trials of antihypertensive drugs: a network meta-analysis. Lancet. 2007; 369:201–207. PMID: 17240286.

23. Ning M, Zhang Q, Yang M. Comparison of self-reported and biomedical data on hypertension and diabetes: findings from the China Health and Retirement Longitudinal Study (CHARLS). BMJ Open. 2016; 6:e009836.